Welcome to UHN Shanghai R&D Co. Ltd. (UHN Shanghai), a WOFE owned by University Health Network of Toronto,Ontario,Canada (UHNToronto). UHNShanghai was founded by bioorganic chemical, pharmaceutical and biological veterans from Canada and China in 2006. Our mission is to provide high quality, innovative products and Chemistry custom service to our valuable clients who range from academic institutes to private organizations.
UHNShanghai headquartered at Zhangjiang High-Tech Park in Pudong District, a major biomedical research and development area, with 2,000 sq ft chemistry laboratories and pilot plant, UHNShanghai also has offices in Toronto, Canada, at University Health Network(UHN), the largest research hospital in Canada and fully affiliated with the University of Toronto. UHN includes three hospitals (Princess Margaret Hospital, Toronto General Hospital, and Toronto Western Hospital) and 5 Research Institutes (Ontario Cancer Institute, Campbell Family Institute for Cancer Research, Campbell Family Institute for Breast Cancer Research, Toronto General Research Institute, and Toronto Western Research Institute). There are more than 2000 research staff working including trainees and research spending exceeds $200M. UHNShanghai is a wholly-owned subsidiary of UHN.
UHNShanghai offers advanced chemical reagents and pharmaceutical intermediates to worldwide pharmaceutical, biotech and chemical industries for their research & development. Our products are focused on novel with drug-like properties, hundreds of molecules are added to our catalog every month and the search engine is updated weekly.
UHNShanghai is also dedicated to providing our clients with high quality, fast, and cost-effective services in custom synthesis (>95% purity, mg, gram, kg scale) which can include reference compound synthesis, building block synthesis, scaffold synthesis, combinatorial library synthesis, key and advanced intermediates synthesis, target synthesis, high-throughput synthesis and purification, and small molecular drug discovery.